**Core Concept**
The carboxylation of clotting factors by Vitamin K is a critical step in the production of functional coagulation proteins. This process involves the carboxylation of specific glutamate residues to form gamma-carboxyglutamate (Gla), which is essential for the binding of calcium ions and the subsequent activation of coagulation cascades.

**Why the Correct Answer is Right**
The correct answer is glutamate (Glu). During the carboxylation process, Vitamin K-dependent carboxylase adds a carboxyl group (-COOH) to the gamma-carbon of glutamate residues in clotting factors, including prothrombin, factor VII, IX, and X. This post-translational modification is essential for the proper functioning of these proteins, as it allows them to bind calcium ions and interact with phospholipid surfaces.

**Why Each Wrong Option is Incorrect**
**Option A:** Aspartate (Asp) is also an acidic amino acid, but it is not the target of Vitamin K-dependent carboxylation. While aspartate can participate in various biochemical reactions, it is not directly involved in the coagulation cascade.
**Option B:** Alanine (Ala) is a non-polar, aliphatic amino acid that does not participate in the carboxylation reaction. Its side chain is not suitable for carboxylation, and it does not play a role in the coagulation cascade.
**Option C:** Arginine (Arg) is a basic amino acid that is involved in various biochemical reactions, but it is not the target of Vitamin K-dependent carboxylation. Its side chain is not suitable for carboxylation, and it does not play a role in the coagulation cascade.

**Clinical Pearl / High-Yield Fact**
Warfarin, a Vitamin K antagonist, inhibits the Vitamin K-dependent carboxylase enzyme, leading to the production of clotting factors that are not properly carboxylated. This results in a decrease in the production of functional coagulation proteins, which can lead to bleeding complications.

**Correct Answer:** C. Glutamate (Glu)